{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:02:58Z","timestamp":1789401778986,"version":"build-2803163510"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"FEDER co-funding and Ministerio de Economia y Competitividad , Spain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07166-w","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:16:28Z","timestamp":1789352188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Topiramate effects on ethanol and sucrose binge-like intake, anxiety- and compulsive-like behavior in non-dependent male and female C57BL\/6J mice"],"prefix":"10.1007","author":[{"given":"Elisa","family":"Rodr\u00edguez-Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Cubero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"7166_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pbb.2015.04.012","volume":"134","author":"M Alcaraz-Iborra","year":"2015","unstructured":"Alcaraz-Iborra M, Cubero I (2015) Do Orexins contribute to impulsivity-driven binge consumption of rewarding stimulus and transition to drug\/food dependence? Pharmacol Biochem Behav 134:31\u201334. https:\/\/doi.org\/10.1016\/j.pbb.2015.04.012","journal-title":"Pharmacol Biochem Behav"},{"key":"7166_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbr.2014.06.049","volume":"272","author":"M Alcaraz-Iborra","year":"2014","unstructured":"Alcaraz-Iborra M, Carvajal F, Lerma-Cabrera JM, Valor LM, Cubero I (2014) Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL\/6J mice: Pharmacological and molecular evidence of orexin involvement. Behav Brain Res 272:93\u201399. https:\/\/doi.org\/10.1016\/j.bbr.2014.06.049","journal-title":"Behav Brain Res"},{"key":"7166_CR3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787","volume-title":"text rev","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association (2022) Diagnostic and Statistical Manual of Mental Disorders. text rev, 5th edn. American Psychiatric Publishing, Washington DC. https:\/\/doi.org\/10.1176\/appi.books.9780890425787","edition":"5"},{"key":"7166_CR4","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1471-4159.2012.07739.x","volume":"121","author":"M Angoa-P\u00e9rez","year":"2013","unstructured":"Angoa-P\u00e9rez M, Kane MJ, Briggs DI, Sykes CE, Shah MM, Francescutti DM, Rosenberg DR, Thomas DM, Kuhn DM (2013) Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. J Neurochem 121:974\u2013984. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07739.x","journal-title":"J Neurochem"},{"key":"7166_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s13668-026-00729-5","volume":"15","author":"A Atar","year":"2026","unstructured":"Atar A (2026) Neurobiological consequences of high-fat high-sugar diets on the mesocorticolimbic system: A narrative review. Curr Nutr Rep 15:6. https:\/\/doi.org\/10.1007\/s13668-026-00729-5","journal-title":"Curr Nutr Rep"},{"key":"7166_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/978-1-61779-458-2_23","volume":"829","author":"NM Avena","year":"2012","unstructured":"Avena NM, Bocarsly ME, Hoebel BG (2012) Animal models of sugar and fat bingeing: Relationship to food addiction and increased body weight. Methods Mol Biol 829:351\u2013365. https:\/\/doi.org\/10.1007\/978-1-61779-458-2_23","journal-title":"Methods Mol Biol"},{"key":"7166_CR101","doi-asserted-by":"publisher","first-page":"110625","DOI":"10.1016\/j.pnpbp.2022.110625","volume":"120","author":"A Bahi","year":"2023","unstructured":"Bahi A, Dreyer JL (2023) Effects of chronic psychosocial stress on binge-like sucrose intake in mice. Prog Neuropsychopharmacol Biol Psychiatry 120:110625. https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110625","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7166_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.psychres.2019.01.007","volume":"273","author":"A Bahji","year":"2019","unstructured":"Bahji A, Mazhar MN, Hudson CC, Nadkarni P, MacNeil BA, Hawken E (2019) Prevalence of substance use disorder comorbidity among individuals with eating disorders: A systematic review and meta-analysis. Psychiatry Res 273:58\u201366. https:\/\/doi.org\/10.1016\/j.psychres.2019.01.007","journal-title":"Psychiatry Res"},{"key":"7166_CR8","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1111\/j.1360-0443.2008.02355.x","volume":"103","author":"DA Baltieri","year":"2008","unstructured":"Baltieri DA, Dar\u00f3 FR, Ribeiro PL, De Andrade AG (2008) Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 103:2035\u20132044. https:\/\/doi.org\/10.1111\/j.1360-0443.2008.02355.x","journal-title":"Addiction"},{"key":"7166_CR9","doi-asserted-by":"publisher","first-page":"R622","DOI":"10.1152\/ajpregu.00087.2009","volume":"297","author":"NT Bello","year":"2009","unstructured":"Bello NT, Guarda AS, Terrillion CE, Redgrave GW, Coughlin JW, Moran TH (2009) Repeated binge access to a palatable food alters feeding behavior, hormone profile, and hindbrain c-Fos responses to a test meal in adult male rats. Am J Physiol Regul Integr Comp Physiol 297:R622\u2013R631. https:\/\/doi.org\/10.1152\/ajpregu.00087.2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"7166_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/add.15155","volume":"116","author":"K Bogusz","year":"2021","unstructured":"Bogusz K, Kopera M, Jakubczyk A, Trucco EM, Kucharska K, Walenda A, Wojnar M (2021) Prevalence of alcohol use disorder among individuals who binge eat: a systematic review and meta-analysis. Addiction 116:18\u201331. https:\/\/doi.org\/10.1111\/add.15155","journal-title":"Addiction"},{"key":"7166_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/01.nmd.0000244481.63148.98","volume":"194","author":"J Bolton","year":"2006","unstructured":"Bolton J, Cox B, Clara I, Sareen J (2006) Use of alcohol and drugs to self-medicate anxiety disorders in a nationally representative sample. J Nerv Ment Dis 194:818\u2013825. https:\/\/doi.org\/10.1097\/01.nmd.0000244481.63148.98","journal-title":"J Nerv Ment Dis"},{"key":"7166_CR12","doi-asserted-by":"publisher","first-page":"110717","DOI":"10.1016\/j.pnpbp.2023.110717","volume":"123","author":"RM Brown","year":"2023","unstructured":"Brown RM, James MH (2023) Binge eating, overeating and food addiction: Approaches for examining food overconsumption in laboratory rodents. Prog Neuropsychopharmacol Biol Psychiatry 123:110717. https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110717","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7166_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M15-2455","volume":"165","author":"KA Brownley","year":"2016","unstructured":"Brownley KA, Berkman ND, Peat CM, Lohr KN, Cullen KE, Bann CM, Bulik CM (2016) Binge-Eating Disorder in Adults. Ann Intern Med 165:409\u2013420. https:\/\/doi.org\/10.7326\/M15-2455","journal-title":"Ann Intern Med"},{"key":"7166_CR14","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.4088\/jcp.v65n0718","volume":"65","author":"CM Bulik","year":"2004","unstructured":"Bulik CM, Klump KL, Thornton L, Kaplan AS, Devlin B, Fichter MM, Halmi KA, Strober M, Woodside DB, Crow S, Mitchell JE, Rotondo A, Mauri M, Cassano GB, Keel PK, Berrettini WH, Kaye WH (2004) Alcohol use disorder comorbidity in eating disorders: A multicenter study. J Clin Psychiatry 65:1000\u20131006. https:\/\/doi.org\/10.4088\/jcp.v65n0718","journal-title":"J Clin Psychiatry"},{"key":"7166_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/01.wnr.0000093484.65585.48","volume":"15","author":"E Cagetti","year":"2004","unstructured":"Cagetti E, Baicy KJ, Olsen RW (2004) Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats. NeuroReport 15:207\u2013210. https:\/\/doi.org\/10.1097\/01.wnr.0000093484.65585.48","journal-title":"NeuroReport"},{"key":"7166_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbr.2015.03.046","volume":"287","author":"F Carvajal","year":"2015","unstructured":"Carvajal F, Alcaraz-Iborra M, Lerma-Cabrera JM, de la Fuente L, Sanchez-Amate C, Cubero I (2015) Orexin receptor 1 signaling contributes to ethanol binge-like drinking: Pharmacological and molecular evidence. Behav Brain Res 287:230\u2013237. https:\/\/doi.org\/10.1016\/j.bbr.2015.03.046","journal-title":"Behav Brain Res"},{"key":"7166_CR17","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jaac.2010.08.017","volume":"49","author":"BJ Casey","year":"2010","unstructured":"Casey BJ, Jones RM (2010) Neurobiology of the adolescent brain and behavior: implications for substance use disorders. J Am Acad Child Adolesc Psychiatry 49:1189\u20131201. https:\/\/doi.org\/10.1016\/j.jaac.2010.08.017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"7166_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0741-8329(02)00199-4","volume":"26","author":"JA Chester","year":"2002","unstructured":"Chester JA, Cunningham CL (2002) GABAA receptor modulation of the rewarding and aversive effects of ethanol. Alcohol 26:131\u2013143. https:\/\/doi.org\/10.1016\/S0741-8329(02)00199-4","journal-title":"Alcohol"},{"key":"7166_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00213-008-1442-y","volume":"204","author":"C Cifani","year":"2009","unstructured":"Cifani C, Polidori C, Melotto S, Ciccocioppo R, Massi M (2009) A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: Effect of sibutramine, fluoxetine, topiramate, and midazolam. Psychopharmacology 204:113\u2013125. https:\/\/doi.org\/10.1007\/s00213-008-1442-y","journal-title":"Psychopharmacology"},{"key":"7166_CR20","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.4088\/jcp.v68n0901","volume":"68","author":"AM Claudino","year":"2007","unstructured":"Claudino AM, de Oliveira IR, Appolinario JC, Cord\u00e1s TA, Duchesne M, Sichieri R, Bacaltchuk J (2007) Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. J Clin Psychiatry 68:1324\u20131332. https:\/\/doi.org\/10.4088\/jcp.v68n0901","journal-title":"J Clin Psychiatry"},{"key":"7166_CR21","doi-asserted-by":"publisher","first-page":"115888","DOI":"10.1016\/j.bbr.2025.115888","volume":"497","author":"I Coppola","year":"2026","unstructured":"Coppola I, De Magistris M, Macchioni G, Calamandrei G, Ricceri L, Tartaglione AM (2026) Beyond marbles buried: a multidimensional analysis of the marble burying test in the C57BL\/6J mouse strain. Behav Brain Res 497:115888. https:\/\/doi.org\/10.1016\/j.bbr.2025.115888","journal-title":"Behav Brain Res"},{"key":"7166_CR22","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.addbeh.2012.12.018","volume":"38","author":"JM Corr\u00eaa Filho","year":"2013","unstructured":"Corr\u00eaa Filho JM, Baltieri DA (2013) A pilot study of full-dose ondansetron to treat heavy-drinking men withdrawing from alcohol in Brazil. Addict Behav 38:2044\u20132051. https:\/\/doi.org\/10.1016\/j.addbeh.2012.12.018","journal-title":"Addict Behav"},{"key":"7166_CR23","doi-asserted-by":"publisher","first-page":"e13936","DOI":"10.1111\/obr.13936","volume":"26","author":"GPA Costa","year":"2025","unstructured":"Costa GPA, Assun\u00e7\u00e3o BR, Belfort-DeAguiar R, Nunes JC (2025) Pharmacotherapies for Binge Eating Disorder: Systematic Review and Network Meta-Analysis. Obes Rev 26:e13936. https:\/\/doi.org\/10.1111\/obr.13936","journal-title":"Obes Rev"},{"key":"7166_CR100","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/acer.12145","volume":"37","author":"BR Cox","year":"2013","unstructured":"Cox BR, Olney JJ, Lowery-Gionta EG, Sprow GM, Rinker JA, Navarro M, Kash TL, Thiele TE (2013) Repeated cycles of binge-like ethanol (EtOH)-drinking in male C57BL\/6J mice augments subsequent voluntary EtOH intake but not other dependence-like phenotypes. Alcohol Clin Exp Res 37:1688\u20131695. https:\/\/doi.org\/10.1111\/acer.12145","journal-title":"Alcohol Clin Exp Res"},{"key":"7166_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1749-6632.2010.05895.x","volume":"1216","author":"JC Crabbe","year":"2011","unstructured":"Crabbe JC, Harris RA, Koob GF (2011) Preclinical studies of alcohol binge drinking. Ann NY Acad Sci 1216:24\u201340. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05895.x","journal-title":"Ann NY Acad Sci"},{"key":"7166_CR25","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/oby.2010.46","volume":"18","author":"TA Czyzyk","year":"2010","unstructured":"Czyzyk TA, Sahr AE, Statnick MA (2010) A model of binge-like eating behavior in mice that does not require food deprivation or stress. Obesity 18:1710\u20131717. https:\/\/doi.org\/10.1038\/oby.2010.46","journal-title":"Obesity"},{"key":"7166_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0165-6147(00)88973-7","volume":"16","author":"GR Dawson","year":"1995","unstructured":"Dawson GR, Tricklebank MD (1995) Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16:33\u201336. https:\/\/doi.org\/10.1016\/S0165-6147(00)88973-7","journal-title":"Trends Pharmacol Sci"},{"key":"7166_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.pnpbp.2004.11.021","volume":"29","author":"C De Bernardi","year":"2005","unstructured":"De Bernardi C, Ferraris S, D\u2019Innella P, Do F, Torre E (2005) Topiramate for binge eating disorder. Prog Neuropsychopharmacol Biol Psychiatry 29:339\u2013341. https:\/\/doi.org\/10.1016\/j.pnpbp.2004.11.021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7166_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40801-015-0053-2","volume":"3","author":"V De Iuliis","year":"2016","unstructured":"De Iuliis V, Gelormini R, Flacco M, Moriello G, Caruso M, Barone E, Golato M, Toniato E, Conti P, Martinotti S (2016) Comparison of Serum Total Valproic Acid Levels and %CDT Values in Chronic Alcohol Addictive Patients in an Italian Clinic: A Retrospective Study. Drugs Real World Outcomes 3:7\u201312. https:\/\/doi.org\/10.1007\/s40801-015-0053-2","journal-title":"Drugs Real World Outcomes"},{"key":"7166_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jsat.2007.05.012","volume":"34","author":"AA De Sousa","year":"2008","unstructured":"De Sousa AA, De Sousa J, Kapoor H (2008) An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence. J Subst Abuse Treat 34:460\u2013463. https:\/\/doi.org\/10.1016\/j.jsat.2007.05.012","journal-title":"J Subst Abuse Treat"},{"key":"7166_CR30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/s0197-0186(00)00061-9","volume":"37","author":"PR Dodd","year":"2000","unstructured":"Dodd PR, Beckmann AM, Davidson MS, Wilce PA (2000) Glutamate-mediated transmission, alcohol, and alcoholism. Neurochem Int 37:509\u2013533. https:\/\/doi.org\/10.1016\/s0197-0186(00)00061-9","journal-title":"Neurochem Int"},{"key":"7166_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/alcalc\/agm047","volume":"42","author":"JM Farook","year":"2007","unstructured":"Farook JM, Morrell DJ, Lewis BEN, Littleton JM, Barron S (2007) Topiramate reduces conditioned abstinence behaviours and handling-induced convulsions after chronic administration of alcohol in Swiss-Webster mice. Alcohol Alcohol 42:296\u2013300. https:\/\/doi.org\/10.1093\/alcalc\/agm047","journal-title":"Alcohol Alcohol"},{"key":"7166_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fgene.2018.00325","volume":"9","author":"DA Finn","year":"2018","unstructured":"Finn DA, Hashimoto JG, Cozzoli DK, Helms ML, Nipper MA, Kaufman MN, Wiren KM, Guizzetti M (2018) Binge Ethanol Drinking Produces Sexually Divergent and Distinct Changes in Nucleus Accumbens Signaling Cascades and Pathways in Adult C57BL\/6J mice. Front Genet 9:325. https:\/\/doi.org\/10.3389\/fgene.2018.00325","journal-title":"Front Genet"},{"key":"7166_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000320471","volume":"17","author":"G Fl\u00f3rez","year":"2010","unstructured":"Fl\u00f3rez G, Saiz PA, Garc\u00eda-Portilla P, \u00c1lvarez S, Nogueiras L, Bobes J (2010) Topiramate for the treatment of alcohol dependence: Comparison with naltrexone. Eur Addict Res 17:29\u201336. https:\/\/doi.org\/10.1159\/000320471","journal-title":"Eur Addict Res"},{"key":"7166_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/01.ALC.0000150014.79657.64","volume":"29","author":"KI Gabriel","year":"2005","unstructured":"Gabriel KI, Cunningham CL (2005) Effects of Topiramate on Ethanol and Saccharin Consumption and Preferences in C57BL\/6J Mice. Alcohol Clin Exp Res 29:75\u201380. https:\/\/doi.org\/10.1097\/01.ALC.0000150014.79657.64","journal-title":"Alcohol Clin Exp Res"},{"key":"7166_CR35","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/ajcn\/nqy342","volume":"109","author":"M Galmiche","year":"2019","unstructured":"Galmiche M, D\u00e9chelotte P, Lambert G, Tavolacci MP (2019) Prevalence of eating disorders over the 2000\u20132018 period: A systematic literature review. Am J Clin Nutr 109:1402\u20131413. https:\/\/doi.org\/10.1093\/ajcn\/nqy342","journal-title":"Am J Clin Nutr"},{"key":"7166_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1037\/a0027999","volume":"20","author":"M Gianoli","year":"2012","unstructured":"Gianoli M, Jane J (2012) Treatment for comorbid borderline personality disorder and alcohol use disorders: A review of the evidence and future recommendations. Exp Clin Psychopharmacol 20:333\u2013344. https:\/\/doi.org\/10.1037\/a0027999","journal-title":"Exp Clin Psychopharmacol"},{"key":"7166_CR37","first-page":"185","volume":"31","author":"NW Gilpin","year":"2008","unstructured":"Gilpin NW, Koob GF (2008) Neurobiology of Alcohol Dependence: Focus on motivational mechanisms. Alcohol Res Health 31:185\u2013195","journal-title":"Alcohol Res Health"},{"key":"7166_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.brat.2015.05.003","volume":"71","author":"CM Grilo","year":"2015","unstructured":"Grilo CM, Ivezaj V, White MA (2015) Evaluation of the DSM-5 severity indicator for binge eating disorder in a clinical sample. Behav Res Ther 71:110\u2013114. https:\/\/doi.org\/10.1016\/j.brat.2015.05.003","journal-title":"Behav Res Ther"},{"key":"7166_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40263-015-0244-0","volume":"29","author":"R Guglielmo","year":"2015","unstructured":"Guglielmo R, Martinotti G, Quatrale M, Ioime L, Kadilli I, Di Nicola M, Janiri L (2015) Topiramate in Alcohol Use Disorders: Review and Update. CNS Drugs 29:383\u2013395. https:\/\/doi.org\/10.1007\/s40263-015-0244-0","journal-title":"CNS Drugs"},{"key":"7166_CR40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3238\/arztebl.m2023.0246","volume":"121","author":"G Halbeisen","year":"2024","unstructured":"Halbeisen G, Laskowski N, Brandt G, Waschescio U, Paslakis G (2024) Eating Disorders in Men. Dtsch Arztebl Int 121:86\u201391. https:\/\/doi.org\/10.3238\/arztebl.m2023.0246","journal-title":"Dtsch Arztebl Int"},{"key":"7166_CR41","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1530-0277.2007.00485.x","volume":"31","author":"GA Hargreaves","year":"2007","unstructured":"Hargreaves GA, McGregor IS (2007) Topiramate Moderately Reduces the Motivation to Consume Alcohol and Has a Marked Antidepressant Effect in Rats. Alcohol Clin Exp Res 31:1900\u20131907. https:\/\/doi.org\/10.1111\/j.1530-0277.2007.00485.x","journal-title":"Alcohol Clin Exp Res"},{"key":"7166_CR42","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1177\/02698811211032475","volume":"36","author":"DJ Heal","year":"2022","unstructured":"Heal DJ, Smith SL (2022) Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology. J Psychopharmacol 36:680\u2013703. https:\/\/doi.org\/10.1177\/02698811211032475","journal-title":"J Psychopharmacol"},{"key":"7166_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.psychres.2015.09.019","volume":"230","author":"SG Helton","year":"2015","unstructured":"Helton SG, Lohoff FW (2015) Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders. Psychiatry Res 230:121\u2013129. https:\/\/doi.org\/10.1016\/j.psychres.2015.09.019","journal-title":"Psychiatry Res"},{"key":"7166_CR102","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fnbeh.2017.00029","volume":"11","author":"JY Holgate","year":"2017","unstructured":"Holgate JY, Shariff M, Mu EWH, Bartlett S (2017) A rat drinking in the dark model for studying ethanol and sucrose consumption. Front Behav Neurosci 11:29. https:\/\/doi.org\/10.3389\/fnbeh.2017.00029","journal-title":"Front Behav Neurosci"},{"key":"7166_CR44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev.clinpsy.4.022007.141157","volume":"4","author":"WG Iacono","year":"2008","unstructured":"Iacono WG, Malone SM, McGue M (2008) Behavioral disinhibition and the development of early-onset addiction: common and specific influences. Annu Rev Clin Psychol 4:325\u2013348. https:\/\/doi.org\/10.1146\/annurev.clinpsy.4.022007.141157","journal-title":"Annu Rev Clin Psychol"},{"key":"7166_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neulet.2009.12.048","volume":"471","author":"M Iijima","year":"2010","unstructured":"Iijima M, Kurosu S, Chaki S (2010) Effects of agents targeting glutamatergic systems on marble-burying behavior. Neurosci Lett 471:63\u201365. https:\/\/doi.org\/10.1016\/j.neulet.2009.12.048","journal-title":"Neurosci Lett"},{"key":"7166_CR46","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/healthcare13131524","volume":"13","author":"J Jeong","year":"2025","unstructured":"Jeong J, Jang J, Jeon G, Baek K (2025) Cognitive and mental health profiles of binge-eating adults with and without comorbid addictive behaviors. Healthcare 13:1524. https:\/\/doi.org\/10.3390\/healthcare13131524","journal-title":"Healthcare"},{"key":"7166_CR47","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1586\/14737175.4.5.751","volume":"4","author":"BA Johnson","year":"2004","unstructured":"Johnson BA (2004) Uses of topiramate in the treatment of alcohol dependence. Expert Rev Neurother 4:751\u2013758. https:\/\/doi.org\/10.1586\/14737175.4.5.751","journal-title":"Expert Rev Neurother"},{"key":"7166_CR48","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","volume":"361","author":"BA Johnson","year":"2003","unstructured":"Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003) Oral topiramate for treatment of alcohol dependence: A randomised controlled trial. Lancet 361:1677\u20131685. https:\/\/doi.org\/10.1016\/S0140-6736(03)13370-3","journal-title":"Lancet"},{"key":"7166_CR49","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","volume":"298","author":"BA Johnson","year":"2007","unstructured":"Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O\u2019Malley SS, Swift RM (2007) Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298:1641\u20131651. https:\/\/doi.org\/10.1001\/jama.298.14.1641","journal-title":"JAMA"},{"key":"7166_CR50","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1001\/archinte.168.11.1188","volume":"168","author":"BA Johnson","year":"2008","unstructured":"Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Addolorato G, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O\u2019Malley SS, Swift RM (2008) Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med 168:1188\u20131199. https:\/\/doi.org\/10.1001\/archinte.168.11.1188","journal-title":"Arch Intern Med"},{"key":"7166_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13293-023-00511-0","volume":"14","author":"L Karlsson Lind","year":"2023","unstructured":"Karlsson Lind L, Rydberg DM, Schenck-Gustafsson K (2023) Sex and gender differences in drug treatment: Experiences from the knowledge database Janusmed Sex and Gender. Biol Sex Differ 14:28. https:\/\/doi.org\/10.1186\/s13293-023-00511-0","journal-title":"Biol Sex Differ"},{"key":"7166_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fpsyt.2013.00072","volume":"4","author":"GF Koob","year":"2013","unstructured":"Koob GF (2013) Addiction is a reward deficit and stress surfeit disorder. Front Psychiatry 4:72. https:\/\/doi.org\/10.3389\/fpsyt.2013.00072","journal-title":"Front Psychiatry"},{"key":"7166_CR53","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2009","unstructured":"Koob GF, Volkow ND (2009) Neurocircuitry of Addiction. Neuropsychopharmacology 35:217\u2013238. https:\/\/doi.org\/10.1038\/npp.2009.110","journal-title":"Neuropsychopharmacology"},{"key":"7166_CR54","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12888-024-05943-5","volume":"24","author":"E Kowalewska","year":"2024","unstructured":"Kowalewska E, Bzowska M, Engel J, Lew-Starowicz M (2024) Comorbidity of binge eating disorder and other psychiatric disorders: A systematic review. BMC Psychiatry 24:556. https:\/\/doi.org\/10.1186\/s12888-024-05943-5","journal-title":"BMC Psychiatry"},{"key":"7166_CR55","doi-asserted-by":"publisher","unstructured":"Lev-Ran S, Feingold D, Fox J (2016) Substance Use Disorders and Comorbid Mental Illness: A Focus on Epidemiological Data Regarding Mood and Anxiety Disorders. Neuropathology of Drug Addictions and Substance Misuse, vol 3. Elsevier Inc, pp 25\u201334. https:\/\/doi.org\/10.1016\/B978-0-12-800634-4.00003-2","DOI":"10.1016\/B978-0-12-800634-4.00003-2"},{"key":"7166_CR56","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1016\/j.immuni.2010.12.017","volume":"257","author":"EG Lowery-Gionta","year":"2012","unstructured":"Lowery-Gionta EG, Navarro M, Chia L, Pleil KE, Rinker JA, Cox BR, Sprow GM, Kash TL, Thiele TE (2012) Corticotropin Releasing Factor Signaling in the Central Amygdala is Recruited During Binge-Like Ethanol Consumption in C57BL\/6J Mice. J Neurosci 257:3405\u20133413. https:\/\/doi.org\/10.1016\/j.immuni.2010.12.017","journal-title":"J Neurosci"},{"key":"7166_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00213-011-2253-0","volume":"217","author":"WJ Lynch","year":"2011","unstructured":"Lynch WJ, Bond C, Breslin FJ, Johnson BA (2011) Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse. Psychopharmacology 217:3\u201312. https:\/\/doi.org\/10.1007\/s00213-011-2253-0","journal-title":"Psychopharmacology"},{"key":"7166_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/0269881108089596","volume":"23","author":"G Martinotti","year":"2009","unstructured":"Martinotti G, Di Nicola M, Di Giannantonio M, Janiri L (2009) Aripiprazole in the treatment of patients with alcohol dependence: A double-blind, comparison trial vs. Naltrexone J Psychopharmacol 23:123\u2013129. https:\/\/doi.org\/10.1177\/0269881108089596","journal-title":"Naltrexone J Psychopharmacol"},{"key":"7166_CR59","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/JCP.0000000000000228","volume":"34","author":"G Martinotti","year":"2014","unstructured":"Martinotti G, Di Nicola M, De Vita O, Hatzigiakoumis DS, Guglielmo R, Santucci B, Aliotta F, Romanelli R, Verrastro V, Petruccelli F, Di Giannantonio M, Janiri L (2014) Low-Dose Topiramate in Alcohol Dependence. J Clin Psychopharmacol 34:709\u2013715. https:\/\/doi.org\/10.1097\/JCP.0000000000000228","journal-title":"J Clin Psychopharmacol"},{"key":"7166_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1176\/appi.ajp.160.2.255","volume":"160","author":"SL McElroy","year":"2003","unstructured":"McElroy SL, Arnold LM, Shapira NA, Keck PE, Rosenthal NR, Karim MR, Kamin M, Hudson JI (2003) Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial. Am J Psychiatry 160:255\u2013261. https:\/\/doi.org\/10.1176\/appi.ajp.160.2.255","journal-title":"Am J Psychiatry"},{"key":"7166_CR61","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.08.008","volume":"61","author":"SL McElroy","year":"2007","unstructured":"McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR (2007) Topiramate for the Treatment of Binge Eating Disorder Associated With Obesity: A Placebo-Controlled Study. Biol Psychiatry 61:1039\u20131048. https:\/\/doi.org\/10.1016\/j.biopsych.2006.08.008","journal-title":"Biol Psychiatry"},{"key":"7166_CR62","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.peptides.2010.03.012","volume":"31","author":"M Molina-Hern\u00e1ndez","year":"2010","unstructured":"Molina-Hern\u00e1ndez M, T\u00e9llez-Alc\u00e1ntara NP, Olivera-L\u00f3pez JI, Jaramillo MT (2010) Antidepressant-like or anxiolytic-like actions of topiramate alone or co-administered with intra-lateral septal infusions of neuropeptide Y in male Wistar rats. Peptides 31:1184\u20131189. https:\/\/doi.org\/10.1016\/j.peptides.2010.03.012","journal-title":"Peptides"},{"key":"7166_CR63","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.pbb.2012.11.002","volume":"103","author":"M Molina-Hern\u00e1ndez","year":"2013","unstructured":"Molina-Hern\u00e1ndez M, T\u00e9llez-Alc\u00e1ntara NP, Olivera-L\u00f3pez JI, Jaramillo MT (2013) Estrous cycle variation in anxiolytic-like effects of topiramate in Wistar rats in two animal models of anxiety-like behavior. Pharmacol Biochem Behav 103:631\u2013636. https:\/\/doi.org\/10.1016\/j.pbb.2012.11.002","journal-title":"Pharmacol Biochem Behav"},{"key":"7166_CR64","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pbb.2013.11.013","volume":"116","author":"CF Moore","year":"2014","unstructured":"Moore CF, Protzuk OA, Johnson BA, Lynch WJ (2014) The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models. Pharmacol Biochem Behav 116:107\u2013115. https:\/\/doi.org\/10.1016\/j.pbb.2013.11.013","journal-title":"Pharmacol Biochem Behav"},{"key":"7166_CR65","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.pnpbp.2011.01.016","volume":"35","author":"A Mowla","year":"2011","unstructured":"Mowla A, Kardeh E (2011) Topiramate augmentation in patients with resistant major depressive disorder: A double-blind placebo-controlled clinical trial. Prog Neuropsychopharmacol Biol Psychiatry 35:970\u2013973. https:\/\/doi.org\/10.1016\/j.pnpbp.2011.01.016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7166_CR66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/jcp.0b013e318059361a","volume":"27","author":"M Mula","year":"2007","unstructured":"Mula M, Pini S, Cassano GB (2007) The Role of Anticonvulsant Drugs in Anxiety Disorders: A Critical Review of the Evidence. J Clin Psychopharmacol 27:263\u2013272. https:\/\/doi.org\/10.1097\/jcp.0b013e318059361a","journal-title":"J Clin Psychopharmacol"},{"key":"7166_CR67","unstructured":"National Institute on Alcohol Abuse and Alcoholism (2024) Understanding alcohol drinking patterns. https:\/\/www.niaaa.nih.gov\/alcohols-effects-health\/alcohol-drinking-patterns. Accessed 3 Jun 2026"},{"key":"7166_CR68","doi-asserted-by":"publisher","unstructured":"Navarrete F, Rubio G, Manzanares J (2010) Effects of naltrexone plus topiramate on ethanol self-administration and tyrosine hydroxylase gene expression changes. Addict Biol 862\u2013873. https:\/\/doi.org\/10.1111\/adb.12058","DOI":"10.1111\/adb.12058"},{"key":"7166_CR70","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/syn.20350","volume":"61","author":"SA Nguyen","year":"2007","unstructured":"Nguyen SA, Malcolm R, Middaugh LD (2007) Topiramate reduces ethanol consumption by C57BL\/6 mice. Synapse 61:150\u2013156. https:\/\/doi.org\/10.1002\/syn.20350","journal-title":"Synapse"},{"key":"7166_CR69","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0091-3057(91)90590-X","volume":"38","author":"K Njung\u2019e","year":"1991","unstructured":"Njung\u2019e K, Handley SL (1991) Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 38:63\u201367. https:\/\/doi.org\/10.1016\/0091-3057(91)90590-X","journal-title":"Pharmacol Biochem Behav"},{"key":"7166_CR71","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1017\/S1092852920001613","volume":"26","author":"M Nourredine","year":"2021","unstructured":"Nourredine M, Jurek L, Auffret M, Iceta S, Grenet G, Kassai B, Cucherat M, Rolland B (2021) Efficacy and safety of topiramate in binge eating disorder: A systematic review and meta-analysis. CNS Spectr 26:459\u2013467. https:\/\/doi.org\/10.1017\/S1092852920001613","journal-title":"CNS Spectr"},{"key":"7166_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-244X-11-41","volume":"11","author":"T Paparrigopoulos","year":"2011","unstructured":"Paparrigopoulos T, Tzavellas E, Karaiskos D, Kourlaba G, Liappas I (2011) Treatment of alcohol dependence with low-dose topiramate: An open-label controlled study. BMC Psychiatry 11:41. https:\/\/doi.org\/10.1186\/1471-244X-11-41","journal-title":"BMC Psychiatry"},{"key":"7166_CR73","doi-asserted-by":"publisher","first-page":"1240748","DOI":"10.3389\/fnbeh.2023.1240748","volume":"17","author":"A Passeri","year":"2023","unstructured":"Passeri A, Municchi D, Cavalieri G, Babicola L, Ventura R, Di Segni M (2023) Linking drug and food addiction: An overview of the shared neural circuits and behavioral phenotype. Front Behav Neurosci 17:1240748. https:\/\/doi.org\/10.3389\/fnbeh.2023.1240748","journal-title":"Front Behav Neurosci"},{"key":"7166_CR74","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/npp.2012.48","volume":"37","author":"L Piccoli","year":"2012","unstructured":"Piccoli L, Di Micioni MV, Cifani C, Costantini VJA, Massagrande M, Montanari D, Martinelli P, Antolini M, Ciccocioppo R, Massi M, Merlo-Pich E, Di Fabio R, Corsi M (2012) Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats. Neuropsychopharmacology 37:1999\u20132011. https:\/\/doi.org\/10.1038\/npp.2012.48","journal-title":"Neuropsychopharmacology"},{"key":"7166_CR75","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659\u2013661. https:\/\/doi.org\/10.1096\/fj.07-9574LSF","journal-title":"FASEB J"},{"key":"7166_CR76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.physbeh.2004.10.007","volume":"84","author":"JS Rhodes","year":"2005","unstructured":"Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC (2005) Evaluation of a simple model of ethanol drinking to intoxication in C57BL\/6J mice. Physiol Behav 84:53\u201363. https:\/\/doi.org\/10.1016\/j.physbeh.2004.10.007","journal-title":"Physiol Behav"},{"key":"7166_CR77","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13293-023-00565-0","volume":"14","author":"JK Rivera-Irizarry","year":"2023","unstructured":"Rivera-Irizarry JK, Zallar LJ, Levine OB, Skelly MJ, Boyce JE, Barney T, Kopyto R, Pleil KE (2023) Sex differences in binge alcohol drinking and the behavioral consequences of protracted withdrawal in C57BL\/6J mice. Biol Sex Differ 14:83. https:\/\/doi.org\/10.1186\/s13293-023-00565-0","journal-title":"Biol Sex Differ"},{"key":"7166_CR78","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fnbeh.2018.00177","volume":"12","author":"E Rodr\u00edguez-Ortega","year":"2018","unstructured":"Rodr\u00edguez-Ortega E, de la Fuente L, de Amo E, Cubero I (2018) Environmental enrichment during adolescence acts as a protective and therapeutic tool for ethanol binge-drinking, anxiety-like, novelty seeking and compulsive-like behaviors in C57BL\/6J mice during adulthood. Front Behav Neurosci 12:177. https:\/\/doi.org\/10.3389\/fnbeh.2018.00177","journal-title":"Front Behav Neurosci"},{"key":"7166_CR79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnbeh.2019.00027","volume":"13","author":"E Rodr\u00edguez-Ortega","year":"2019","unstructured":"Rodr\u00edguez-Ortega E, Alcaraz-Iborra M, de la Fuente L, de Amo E, Cubero I (2019a) Environmental enrichment during adulthood reduces sucrose binge-like intake in a high drinking in the dark phenotype (HD) in C57BL\/6J mice. Front Behav Neurosci 13:27. https:\/\/doi.org\/10.3389\/fnbeh.2019.00027","journal-title":"Front Behav Neurosci"},{"key":"7166_CR80","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.appet.2019.03.033","volume":"138","author":"E Rodr\u00edguez-Ortega","year":"2019","unstructured":"Rodr\u00edguez-Ortega E, Alcaraz-Iborra M, de la Fuente L, Cubero I (2019b) Protective and therapeutic benefits of environmental enrichment on binge-like sucrose intake in C57BL\/6J mice. Appetite 138:184\u2013189. https:\/\/doi.org\/10.1016\/j.appet.2019.03.033","journal-title":"Appetite"},{"key":"7166_CR81","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/s-2004-815473","volume":"37","author":"G Rubio","year":"2004","unstructured":"Rubio G, Ponce G, Jim\u00e9nez-Arriero MA, Palomo T, Manzanares J, Ferre F (2004) Effects of Topiramate in the Treatment of Alcohol Dependence. Pharmacopsychiatry 37:37\u201340. https:\/\/doi.org\/10.1055\/s-2004-815473","journal-title":"Pharmacopsychiatry"},{"key":"7166_CR82","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jad.2014.05.015","volume":"166","author":"A Sahraian","year":"2014","unstructured":"Sahraian A, Bigdeli M, Ghanizadeh A, Akhondzadeh S (2014) Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: A randomized double blind placebo controlled clinical trial. J Affect Disord 166:201\u2013205. https:\/\/doi.org\/10.1016\/j.jad.2014.05.015","journal-title":"J Affect Disord"},{"issue":"Suppl 1","key":"7166_CR84","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","volume":"41","author":"RP Shank","year":"2000","unstructured":"Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE (2000) An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41(Suppl 1):S3\u2013S9. https:\/\/doi.org\/10.1111\/j.1528-1157.2000.tb02163.x","journal-title":"Epilepsia"},{"key":"7166_CR85","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/acer.13923","volume":"43","author":"EA Sneddon","year":"2019","unstructured":"Sneddon EA, White RD, Radke AK (2019) Sex Differences in Binge-Like and Aversion-Resistant Alcohol Drinking in C57BL\/6J Mice. Alcohol Clin Exp Res 43:243\u2013249. https:\/\/doi.org\/10.1111\/acer.13923","journal-title":"Alcohol Clin Exp Res"},{"key":"7166_CR86","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1016\/S2468-2667(25)00098-2","volume":"10","author":"A Sz\u00fccs","year":"2025","unstructured":"Sz\u00fccs A, Van Der Lubbe SCC, De La Arias J, Valderas JM, Hay SI, Bisignano C, Morgan BW, Acharya S, Adnani QES, Apostol GLC, Aslam MS, Asri Y, Aung ZZ, Aurizki GE, Baig AA, Bermudez ANC, Cenderadewi M, Danpanichkul P, Efendi F et al (2025) The epidemiology and burden of ten mental disorders in countries of the Association of Southeast Asian Nations (ASEAN), 1990\u20132021: Findings from the Global Burden of Disease Study 2021. Lancet Public Health 10:e480\u2013e491. https:\/\/doi.org\/10.1016\/S2468-2667(25)00098-2","journal-title":"Lancet Public Health"},{"key":"7166_CR87","doi-asserted-by":"publisher","first-page":"173819","DOI":"10.1016\/j.pbb.2024.173819","volume":"242","author":"A Themann","year":"2024","unstructured":"Themann A, Rodriguez M, Reyes-Arce J, I\u00f1iguez SD (2024) Chlordiazepoxide reduces anxiety-like behavior in the adolescent mouse elevated plus maze: a pharmacological validation study. Pharmacol Biochem Behav 242:173819. https:\/\/doi.org\/10.1016\/j.pbb.2024.173819","journal-title":"Pharmacol Biochem Behav"},{"key":"7166_CR88","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.alcohol.2013.08.005","volume":"48","author":"TE Thiele","year":"2014","unstructured":"Thiele TE, Navarro M (2014) Drinking in the dark (DID) procedures: A model of binge-like ethanol drinking in non-dependent mice. Alcohol 48:235\u2013241. https:\/\/doi.org\/10.1016\/j.alcohol.2013.08.005","journal-title":"Alcohol"},{"key":"7166_CR89","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","volume":"204","author":"A Thomas","year":"2009","unstructured":"Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, Paylor R (2009) Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology 204:361\u2013373. https:\/\/doi.org\/10.1007\/s00213-009-1466-y","journal-title":"Psychopharmacology"},{"key":"7166_CR90","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.2174\/138161211796150864","volume":"17","author":"G Thorens","year":"2011","unstructured":"Thorens G, Billieux J, Manghi R, Khan R, Khazaal Y, Zullino DF (2011) The potential interest of topiramate in addiction. Curr Pharm Des 17:1410\u20131415. https:\/\/doi.org\/10.2174\/138161211796150864","journal-title":"Curr Pharm Des"},{"key":"7166_CR91","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejphar.2007.02.016","volume":"563","author":"G Uday","year":"2007","unstructured":"Uday G, Pravinkumar B, Manish W, Sudhir U (2007) LHRH antagonist attenuates the effect of fluoxetine on marble-burying behavior in mice. Eur J Pharmacol 563:155\u2013159. https:\/\/doi.org\/10.1016\/j.ejphar.2007.02.016","journal-title":"Eur J Pharmacol"},{"key":"7166_CR92","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.alcohol.2014.03.002","volume":"48","author":"V Vengeliene","year":"2014","unstructured":"Vengeliene V, Bilbao A, Spanagel R (2014) The alcohol deprivation effect model for studying relapse behavior: a comparison between rats and mice. Alcohol 48:313\u2013320. https:\/\/doi.org\/10.1016\/j.alcohol.2014.03.002","journal-title":"Alcohol"},{"key":"7166_CR93","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2:322\u2013328. https:\/\/doi.org\/10.1038\/nprot.2007.44","journal-title":"Nat Protoc"},{"key":"7166_CR94","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1172\/JCI26436","volume":"115","author":"G Wand","year":"2005","unstructured":"Wand G (2005) The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism. J Clin Invest 115:2697\u20132699. https:\/\/doi.org\/10.1172\/JCI26436","journal-title":"J Clin Invest"},{"key":"7166_CR95","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/pcn.12186","volume":"68","author":"HR Wang","year":"2014","unstructured":"Wang HR, Woo YS, Bahk WM (2014) Potential role of anticonvulsants in the treatment of obsessive-compulsive and related disorders. Psychiatry Clin Neurosci 68:723\u2013732. https:\/\/doi.org\/10.1111\/pcn.12186","journal-title":"Psychiatry Clin Neurosci"},{"key":"7166_CR96","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41386-021-00968-w","volume":"46","author":"RR Wetherill","year":"2021","unstructured":"Wetherill RR, Spilka N, Jagannathan K, Morris P, Romer D, Pond T, Kranzler HR (2021) Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial. Neuropsychopharmacology 46:1407\u20131414. https:\/\/doi.org\/10.1038\/s41386-021-00968-w","journal-title":"Neuropsychopharmacology"},{"key":"7166_CR97","doi-asserted-by":"publisher","first-page":"57","DOI":"10.35946\/arcr.v39.1.09","volume":"39","author":"RW Wilsnack","year":"2018","unstructured":"Wilsnack RW, Wilsnack SC, Gmel G, Kantor LW (2018) Gender Differences in Binge Drinking. Alcohol Res Curr Rev 39:57\u201376. https:\/\/doi.org\/10.35946\/arcr.v39.1.09","journal-title":"Alcohol Res Curr Rev"},{"key":"7166_CR98","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/adb.12349","volume":"22","author":"MM Yardley","year":"2016","unstructured":"Yardley MM, Ray LA (2016) Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol 22:581\u2013615. https:\/\/doi.org\/10.1111\/adb.12349","journal-title":"Addict Biol"},{"key":"7166_CR99","first-page":"1","volume":"58","author":"D Zaremba","year":"2006","unstructured":"Zaremba D, Bia M, Cioczek P (2006) Non-epilepsy uses of antiepileptic drugs. Pharmacol Rep 58:1\u201312","journal-title":"Pharmacol Rep"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07166-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07166-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07166-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:07:14Z","timestamp":1789398434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07166-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":101,"alternative-id":["7166"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07166-w","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}